Pharmaceutical

Japanese Kyowa Kirin acquires Orchard to bolster gene t...

The Japan-based pharmaceutical company Kyowa Kirin has entered into a defin...

AstraZeneca’s Forxiga meets primary endpoint for T2D

AstraZeneca has announced positive results from the T2NOW Phase III trial for p...

EMA endorses Calliditas’ Alport syndrome drug for orpha...

The European Medicines Agency (EMA) has provided a positive opinion for Callidi...

Inhibikase’s risvodetinib wins FDA orphan drug designation

The US Food and Drug Administration (FDA) has granted Inhibikase Therapeutics’ ...

Advanz Pharma to license Dimerix’s DMX-200 drug candidate

Advanz Pharma has signed an agreement to licence Dimerix’s drug candidate DMX-2...

Shorla raises funds to advance oncology drug candidates

US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m ...

UK launches national full-body scan platform to acceler...

The UK national scanning programme, National PET Imaging Platform (NPIP), has b...

FDA issues draft guidance on stimulant use disorder dru...

The US Food and Drug Administration (FDA) has issued a draft guidance to aid sp...

ADCs dominate with billion-dollar licensing agreements ...

Antibody-drug conjugates (ADCs) saw a 400% growth in total licensing agreement ...

Say goodbye to the Covid-19 vaccination card. The CDC h...

It's the end of an era for a once-critical pandemic document: The ubiquitous whi...

STAT+: Was Amgen less than forthcoming about FDA’s conc...

Some analysts are questioning whether Amgen was fully forthcoming about a pricey...

STAT+: Federal bill would keep addiction medication fro...

A bill would address a Catch-22 in some pregnancies: use prescription medication...

Esketamine tops quetiapine for treatment-resistant depr...

Nasal esketamine spray is more effective than an extended-release antipsychotic,...

STAT+: Key Senate panel eyes action on drug shortages

One of the top health care committees in the Senate is assembling ideas for bipa...

STAT+: Consumer watchdog sues diagnostic firm EpicGenet...

The lawsuit filed by the Center for Science in the Public alleges that EpicGenet...

STAT+: To prevent amputation in patients with severe va...

The FDA approved a new surgical device for patients with severe vascular disease...